Pharmacy

Showing 15 posts of 139 posts found.

Five of EU-27 account for 68% of pharma trade, report finds

March 27, 2025
Market Research Logista Freight, Pharmacy, european union, market report, trade

Logista Freight has found that Germany, France, Belgium, Italy and the Netherlands account for up to 68% of trade in …

handshake_2

Cold Chain Technologies acquires Global Cold Chain Solutions

March 26, 2025
Dedicated cold-chain delivery, Manufacturing and Production Global Cold Chain Solutions, Pharmacy, business development, cold chain, life sciences, partnership

Cold Chain Technologies (CCT), a global provider for temperature-sensitive packing and digital solutions, has acquired Global Cold Chain Solutions (GCCS), …

Gary Lyons appointed as EVP medical affairs of Coronado Research

March 26, 2025
Business Services, Consultancy Consultancy, Coronado Research, Medical Affairs, Pharmacy, appointment

Coronado Research, a UK-based consultancy-led organisation, has announced that it has appointed Gary Lyons as executive vice president (EVP) for …

Agilent to acquire BIOVECTRA for $925m

July 24, 2024
Business Services Agilent, CMDO, Pharmacy, acquisition

Agilent Technologies has announced that it has signed a definitive agreement to acquire BIOVECTRA, a leading specialised contract development and …

60 Degrees Pharmaceuticals signs clinical trial agreements with sites for babesiosis study

July 22, 2024
Medical Communications 60 Degrees Pharmaceuticals, Pharmacy, babesiosis, clinical trials

60 Degrees Pharmaceuticals has announced that it has signed clinical trial agreements with all three of its planned trial sites …

Brainomix and Boehringer Ingelheim enter strategic partnership

July 19, 2024
Research and Development Boehringer Ingelheim, Brainomix, Pharmacy, fibrosing lung disease, partnership

Brainomix has announced that it has entered into a strategic partnership with Boehringer Ingelheim for a collaborative programme surrounding the …

Camurus shares phase 3 results from ACROINNOVA 2 study

July 16, 2024
Research and Development Camurus, Pharmacy, acromegaly, clinical trial, injection

Camurus has announced positive results from its 52-week phase 3 open-label ACROINNOVA 2 study, which assessed the safety and efficacy …

Aspect Biosystems announces partnership with governments of Canada and British Columbia

July 11, 2024
Business Services Aspect Biosciences, Pharmacy, government, investment

Aspect Biosystems has announced that it has entered into an agreement with the governments of Canada and British Columbia, under …

Certara to acquire Chemaxon for drug discovery portfolio

July 10, 2024
Business Services Certara, Chemaxon, Pharmacy, acquisition, drug discovery

Certara and Chemaxon have announced that they have signed a definitive agreement under which Certara will acquire Chemaxon. The deal …

Arcturus Therapeutics provides update on OTC deficiency and CF programmes

July 2, 2024
Research and Development Arcturus Therapeutics, OTC, Pharmacy, clinical trials, cystic fibrosis

Arcturus Therapeutics has announced mid-year updates for ARCT-810, an investigational mRNA therapeutic to treat ornithine transcarbamylase (OTC) deficiency, and ARCT-032, …

Nuclera gains £1.14m funding from Innovate UK

June 7, 2024
Research and Development Innovate UK, Nuclera, Pharmacy, grants

Nuclera has announced that it has been awarded two grants from Innovate UK, totalling £1.14m.

Syngene launches new platform for protein production

June 6, 2024
Research and Development ExcellGene, Pharmacy, Syngene, platform, protein production

Syngene has announced the launch of its new protein production platform, which will utilise a cell line and transposon-based technology …

Eli Lilly and UNICEF expand support for young people at risk of noncommunicable diseases

May 30, 2024
Medical Communications Eli Lilly, Pharmacy, Unicef, investment, noncommunicable diseases

Eli Lilly has announced that it will donate $6.5m to the United States Fund for UNICEF in order to expand …

Merck to acquire Mirus Bio for $600m

May 23, 2024
Business Services Merck, Pharmacy, acquisition, gene therapies

Merck has announced that it has signed a definitive agreement to acquire Mirus Bio for $600m.

Sustainability in pharma

May 22, 2024
Pharmacy, Pharmafocus, feature, sustainability

Betsy Goodfellow from Pharmafocus considers the need for sustainable practices in the pharma industry and assesses various sustainable advances that have already …

The Gateway to Local Adoption Series

Latest content